Despropionyl Ramelteon Hydrochloridum CAS 196597-80-5 Puritas >98.0% (HPLC)
Ducens Fabrica et Supplier
Ramelteon intermedia:
Ramelteon (TAK-375) CAS 196597-26-9
2,3-Dihydrobenzofuran CAS 496-16-2
1,2,6,7-Tetrahydro-8H-Indeno[5,4-b]furan-8-one CAS 196597-78-1
Ramelteon Acrylonitrile CAS 196597-79-2
Despropionyl Ramelteon Hydrochloridum CAS 196597-80-5
2-(2,6,7,8-Tetrahydro-1H-Indeno[5,4-b]furan-8-yl)ethanamine Hydrochloride CAS 1053239-39-6
Please contact: alvin@ruifuchem.com
Nomen chemicum | (S)-2-(1,6,7,8-Tetrahydro-2H-Indeno[5,4-b]furan-8-yl) ethylaminum hydrochloridum |
Synonyma | Despropionyl Ramelteon Hydrochloride;(S)-2-(2,6,7,8-Tetrahydro-1H-Indeno[5,4-b]furan-8-yl)ethanamine Hydrochloride;(S)-2-(2,6,7,8-Tetrahydro-1H-Indeno[5,4-b]furan-8-yl)ethanamine HCl;Ramelteon Impuritas 15 HCl;Ramelteon Amine immunditia |
CAS Number | 196597-80-5 |
CATTUS Number | RF2888 |
Stock Status | In Stock, Productio Ascendite ad Tons |
Formulae hypotheticae | C13H17NO.HCl |
M. Pondus | 239.74 |
Liquescens punctum | 270℃ |
Solubilitas in aqua | Solutum in Chloroforme, Dichloromethane, Ethyl acetate, Methanol |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | White ad Off-White solidus pulveris |
Puritas / Analysis Methodus | >98.0% (HPLC) |
Damnum in Siccatio | <1.00% |
una immunditia | <1.00% |
Totalis immunditias | <2.00% |
1 H NMR Spectrum | Congruunt cum Structure |
Test Standard | Enterprise Standard |
Consuetudinem | Ramelteon (CAS: 196597-26-9) |
sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore
Quam mercari?Quaeso contactumDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
15 Years Experience?Plus quam XV annos experientiae habemus in fabricando et exportando amplis intermediis pharmaceuticis vel alchimicis pharmaceuticis amplis.
Mercatus principalis?Vendere mercatum domesticum, Americam septentrionalem, Europam, Indiam, Coream, Iaponicam, Australiam etc.
Commodi?Superior qualitas, parabilis pretium, officia professionalia et subsidia technica, ieiunium partus.
Qualitasfides?Qualitas strictioris temperantiae ratio.Pro instrumento analysi professionali includuntur NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Claritas, Solubilitas, Microbialis limes test, etc.
Exempla?Pleraque producta praebent exempla gratuita pro qualitate aestimationis, sumptus naviculas a clientibus solvendos.
Factory Audit?Factory audit gratissimum.Quaeso ante constitutum.
MOQ?Nec MOQ.Parvus ordo placet.
Tempus adferendi? Si intus prosapia, tres dies partus praestatur.
Transportatio?Per Express (FedEx, DHL), ab Air, per Mare.
Documenta?Post servitium venditionis: COA, MOA, ROS, MSDS, etc. praeberi possunt.
Consuetudo Synthesis?Consuetudo synthesis officia praebere potest ad optimas investigationes tuas necessitates aptandas.
Pensio conditio?Proforma cautionis primum post confirmationem ordinis mittetur, informationes nostrae ripae inclusas.Payment by T/T (Telex Transfer), PayPal, Western Union, etc.
(S)-2-(1,6,7,8-Tetrahydro-2H-Indeno[5,4-b]furan-8-yl) ethylaminum Hydrochloridum, etiam Despropionyl Ramelteon Hydrochloridum appellatum (CAS: 196597-80-5. ) medius Ramelteon (CAS: 196597-26-9).Ramelteon (TAK-375) est receptor melatonini novus receptor agonist humanorum MT1 et MT2 receptorum et pulli forebrain receptores melatonini cum Ki 14 pM, 112 pM et 23.1 pM, respectively.Moleculum melatoninum maxime immutatum est, nitrogenium indolis ringi cum carbone ad anulum indanum dandum et incorporando 5-methoxylum globi in anulo indole indolis in annulum furanum rigidiorem.Selectivity Ramelteon proventuum pro MT1 receptore plus duodequadraginta partibus quam receptae MT2.Dissimilis melatonin, efficacior est in somno incipiendo (actio MT1) quam ad modulum circadianum recensere (actio MT2).Ita distincte efficacior esse videtur quam melatonin sed minus efficax quam benzodiazepinae ut hypnotica.Adipiscing, hoc pharmacum non habet Rusticis obnoxium (non est substantia abstracta).Quam ob rem nuper insomnia curationem approbavit.